Major Site Development At Life Science Park, Rheintal
CDMO Celonic Group, specialised in development and production of Advanced Therapy Medicinal Products (ATMPs) and biotherapeutics, has announced a long-term lease agreement for a new production site and office space spanning 91,500 sqft (8,500 sqm) in the WST-222 building at the Novartis-operated Life Science Park Rheintal.
Comentarios